Abstract:In order to discover antiplatelet drugs with novel structures and expand our research scope, total twenty 1,3-benzenedisulfonyl piperazines, were designed and synthesized. These target compounds were divided into two series, namely 4-methoxy-1,3-benzenedisulfonyl piperazines of series 1 and 4-ethoxy-1,3-benzenedisulfonyl piperazines of series 2. With adenosine diphosphate (ADP), arachidonic acid (AA) and collagen as inducers, respectively, the Born turbidimetric method was used to screen the anti-platelet activity in vitro of all target compounds at a concentration of 1.3 μM, aspirin and picotamide as positive control drugs. And of which, the activity of five compounds for collagen was higher than both picotamide and aspirin. In ADP or AA channel, compounds with an inhibition rate greater than 33% were selected, and their corresponding IC50 values were obtained. According to the IC50, the in vitro activity of one compound for ADP was higher than picotamide, and for AA, two compounds were higher than two positive control drugs and other two compounds only higher than or equal to aspirin. Completed the preliminary analysis of the structure-activity relationship of the compound involved in this study. Further, eight compounds exhibiting the high activity in one or two test channels, were subjected to cytotoxicity test on mouse fibroblasts (L929) by CCK-8 method. The in vitro cytotoxicity of most test compounds showed less than or same to control drug picotamide at 10 μM, but at the higher concentration of 100 μM, merely two compounds exhibited higher cell survival rate than that of picotamide. In addition, compound N1, N3-di (4-ethoxy-1, 3-benzenedisulfonyl)bis(1-(m-tolyl)piperazine), which is delivery activity in the three test channels, and compound N1, N3- di (4-methoxy-1, 3-phenylenedisulfonyl)bis(1-(m-tolyl)piperazine), which is the lowest cytotoxic in vitro compound among series 1 and series 2, respectively, are found and selected for simulation analysis as two most likely to dock with the receptor P2Y12. Each of synthesized compounds in silico molecular property and ADME (absorption, distribution, metabolism and excretion) are predicted by using Molinspiration property engine v2018.10 and PreADMET online servers, respectively. Compared with other series of compounds in the previous stage, the two series compounds obtained after the introduction of piperazinyl have a similar in vitro activity.

Synthesis, Resolution, and Antiplatelet Activity of 3-Substituted 1(3H)-Isobenzofuranone.

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Synthesis, Structural Characterization, Hirshfeld Surface, DFT Calculation and Antifungal Activity of Novel Quinoline Carbonothioate Compounds

Synthesis and biological evaluation of N 6 derivatives of 8-azapurine as novel antiplatelet agents

Synthesis of Novel 3-Butylphthalide Derivatives Containing Isopentenylphenol Moiety as Potential Antiplatelet Agents for the Treatment of Ischemic Stroke

New Approach to Synthesize Symmetrical and Unsymmetrical 6-(N-alkyl(aryl)amino)- and 6-(N,n-dialkyl(aryl)amino)-2,4-bis(alkyl(aryl)thio)pyrimidines As Anti-Platelet Agents

Novel Synthesis Approach and Antiplatelet Activity Evaluation of 6-Alkylamino-2,4-dialkyl(aryl)thiopyrimidines

Synthesis of 3,15-Disuccinate-12-coumarin Substituted Andrographolide Derivatives and Their Antiplatelet Aggregation Activities in Vitro

Synthesis of N-6-Alkyl(Aryl)-2-Alkyl(Aryl)Thioadenosines As Antiplatelet Agents

Synthesis of 2-Alkoxy-N-6-alkyl Adenosine Compounds and Their Anti-platelet Aggregation Activity

Synthesis and Biological Activity of 1,3,4-Thiadiazole Aroylurea Derivatives

ChemInform Abstract: Novel Synthesis Approach and Antiplatelet Activity Evaluation of 6‐Alkylamino‐2,4‐dialkyl(aryl)thiopyrimidines.

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets

Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents

Novel phthalide derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo

Synthesis and Vasodilatation of 2-Substituted-3,4-dihydro-1 (2H)-Isoquinolinones

Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents

Synthesis of new class dipeptide analogues with improved permeability and antithrombotic activity.

Synthesis and Primary Anti-tumor Activities of 3-Fluoro-or 3-Amino-6-substituted-5,6-dihydropyrrolo [3,4-b] pyridin-7-ones

Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents

Synthesis, Molecular Docking, and Hemorheological Activity of New 4-(Thien-2-yl)-3-aminopyridine-2(1H)-one Derivatives